⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6897683 | 0.78 | — | — | |
| SCHEMBL8429764 | 0.77 | — | — | |
| SCHEMBL11346226 | 0.76 | — | — | |
| SCHEMBL3321079 | 0.75 | — | — | |
| SCHEMBL7118357 | 0.75 | — | — | |
| SCHEMBL157962 | 0.75 | — | — | |
| SCHEMBL17744967 | 0.75 | — | — | |
| SCHEMBL427042 | 0.71 | — | — | |
| SCHEMBL8885450 | 0.70 | — | — | |
| SCHEMBL9563447 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12104 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122071704-A | SiRNA targeting bone morphogenetic protein 2, modified siRNA and application thereof | 北京大学 | 2026-05-22 | — | — | CN | claimed |
| CN-122071703-A | SiRNA targeting bone morphogenetic protein 4 gene, modified siRNA and application thereof | 北京大学 | 2026-05-22 | — | — | CN | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260071273-A1 | METHODS FOR NUCLEIC ACID SEQUENCING | NANOHYB LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4677107-A1 | METHOD FOR NATIVE STRAND SEQUENCING OF ENRICHED GENOMIC REGIONS | Nanohyb, LLC (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250346624-A1 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | EISAI R&D MAN CO LTD (JP) | 2025-11-13 | — | — | US | claimed |
| EP-4620970-A1 | PORIN MONOMER, PORIN, MUTANT THEREOF, AND USE THEREOF | BGI Shenzhen (CN) | 2025-09-24 | — | — | EP | claimed |
| EP-4617375-A2 | METHODS, COMPOSITIONS AND SYSTEMS FOR IMPROVING THE BINDING OF METHYLATED POLYNUCLEOTIDES | Guardant Health, Inc. (US) | 2025-09-17 | — | — | EP | claimed |
| EP-3821033-B1 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | HIFIBIO SAS (FR) | 2025-09-10 | — | — | EP | claimed |
| US-20020039741-A1 | Antitumor agent | DEAN NICHOLAS M (US) | 2002-04-04 | — | — | US | claimed |
| EP-0957926-A4 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | ISIS PHARMACEUTICALS INC (US) | 2002-01-23 | — | — | EP | claimed |
| US-6319906-B1 | FOR THERAPY OF AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE, FOR INHIBITING ALLOGRAFT REJECTION | ISIS PHARMACEUTICALS | 2001-11-20 | — | — | US | claimed |
| US-6312900-B1 | FOR MODULATING METASTASIS OF MALIGNANT TUMORS VIA MODULATION OF ACTIVATING PROTEIN 1 | ISIS PHARMACEUTICALS, INC. | 2001-11-06 | — | — | US | claimed |
| JP-2000507833-A | — | — | 2000-06-27 | — | — | JP | claimed |
| US-6077833-A | FOR DIAGNOSIS, PREVENTION AND TREATMENT OF IMMUNE STATES AND DISORDERS AMENABLE TO TREATMENT THROUGH MODULATION OF T CELL ACTIVATION SUCH AS FOR PREVENTING ALLOGRAFT REJECTION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-20 | — | — | US | claimed |
| EP-0957926-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | ISIS PHARMACEUTICALS, INC. (US) | 1999-11-24 | — | — | EP | claimed |
| US-5985558-A | DNA SEQUENCE | ISIS PHARMACEUTICALS INC. (US) | 1999-11-16 | — | — | US | claimed |
| US-5837852-A | PHOSPHORYLATED OLIGONUCLEOTIDE USE AS ANTIINFLUENZA AGENT, ENZYME INHIBITOR NOT DEPHOSPHORYLATED BY VIRAL POLYMERASE AND INHIBITORS OF INFLUENZA TRANSCRIPTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-11-17 | — | — | US | claimed |
| WO-1998029124-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | ISIS PHARMACEUTICALS, INC. (US) | 1998-07-09 | — | — | WO | claimed |